These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10386503)
1. Antioxidant therapy for coronary artery disease: don't paint the walls without treating the termites! Ewy GA Arch Intern Med; 1999 Jun; 159(12):1279-80. PubMed ID: 10386503 [No Abstract] [Full Text] [Related]
2. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Ricciardi MJ; Davidson CJ N Engl J Med; 1999 Dec; 341(24):1854; author reply 1854-5. PubMed ID: 10610465 [No Abstract] [Full Text] [Related]
3. Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease. Isaacsohn JL; Davidson MH; Hunninghake D; Singer R; McLain R; Black DM Am J Cardiol; 2000 Jul; 86(2):250-2. PubMed ID: 10913499 [No Abstract] [Full Text] [Related]
4. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study]. März W MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971 [TBL] [Abstract][Full Text] [Related]
5. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Mikhailidis DP; Wierzbicki AS Curr Med Res Opin; 2002; 18(4):215-9. PubMed ID: 12201622 [No Abstract] [Full Text] [Related]
6. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease. Clearfield M Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005 [No Abstract] [Full Text] [Related]
7. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. Stone PH; Lloyd-Jones DM; Johnstone M; Carlson W; Rubenstein J; Creager M; Frei B; Sopko G; Clark ME; Maccallum G; Kinlay S; Orav J; Selwyn AP Am Heart J; 2004 May; 147(5):875-82. PubMed ID: 15131545 [TBL] [Abstract][Full Text] [Related]
8. ["Treating to New Targets": plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease]. Scheen AJ Rev Med Liege; 2005 Apr; 60(4):264-7. PubMed ID: 15943105 [TBL] [Abstract][Full Text] [Related]
9. [For coronary disease patients is certain: the lower the LDL the better]. MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797 [No Abstract] [Full Text] [Related]
10. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous coronary intervention versus medical therapy for coronary heart disease. Maron DJ Curr Atheroscler Rep; 2000 Jul; 2(4):290-6. PubMed ID: 11122756 [TBL] [Abstract][Full Text] [Related]
12. Low-density-lipoprotein cholesterol goals for patients with coronary disease: treating between the lines. Waters DD; Hsue PY Circulation; 2001 Nov; 104(22):2635-7. PubMed ID: 11723009 [No Abstract] [Full Text] [Related]